Home Intranet Contact

News item


For questions or if you need more information, please contact us.

Time to market: Progress-PME event in collaboration with HollandBio on November 21st, 2019

14-10-2019 |


Click to enlarge

To get approval of a new biopharmaceutical drug, much time, effort and costs are spent to gather the necessary clinical trial results. However, in order to obtain regulatory approval also the chemistry, manufacturing and control (CMC) module (Module 3 - The Quality section of the CTD) is of vital importance. What should you consider at what stage during drug development? How to prevent delays in regulatory approval as a result of incomplete CMC sections? On November 21st 2019, Progress- PME will organize an event in collaboration with HollandBIO where multiple speakers will share their lessons learned on gathering the required CMC data.

Save your seat!


  • Kees Groen - ORCA Therapeutics
  • Pieter-Jan Vos - Batavia Biosciences
  • Karin Hoogendoorn - ATMP product development

Practical info

  • Date: November 21st
  • Time: 14.30 doors open, 15.00 program 17.00 drinks
  • Venue: Centraal museum, Utrecht
  • Registration: Registration is free via this link 
to the top